Small Molecule Drug Discovery at the Glucagon-Like Peptide-1 Receptor

The therapeutic success of peptide glucagon-like peptide-1 (GLP-1) receptor agonists for the treatment of type 2 diabetes mellitus has inspired discovery efforts aimed at developing orally available small molecule GLP-1 receptor agonists. Although the GLP-1 receptor is a member of the structurally c...

Descripción completa

Detalles Bibliográficos
Autores principales: Willard, Francis S., Bueno, Ana B., Sloop, Kyle W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2012
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3352573/
https://www.ncbi.nlm.nih.gov/pubmed/22611375
http://dx.doi.org/10.1155/2012/709893

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3352573/
https://www.ncbi.nlm.nih.gov/pubmed/22611375
http://dx.doi.org/10.1155/2012/709893

Ejemplares similares